CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$433M
(+4.8%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
255
Reduced
393
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Neurocrine Biosciences
NBIX
$14.3B
| $19.1M | 0.2% |
156,282
-30,484
| -16% | -$3.72M |
|
127
Ball Corp
BALL
$13.8B
| $18.9M | 0.2% |
271,761
+152,954
| +129% | +$10.6M |
|
128
Heron Therapeutics
HRTX
$199M
| $18.8M | 0.2% |
1,278,972
+578,462
| +83% | +$8.51M |
|
129
Moderna
MRNA
$9.72B
| $18.6M | 0.2% |
+285,834
| New | +$18.6M |
|
130
Xylem
XYL
$34.1B
| $18.1M | 0.19% |
278,827
-246,681
| -47% | -$16M |
|
131
American Tower
AMT
$93.3B
| $17.9M | 0.19% |
69,411
+18,393
| +36% | +$4.76M |
|
132
Masco
MAS
$15.8B
| $17.8M | 0.19% |
354,109
+249,610
| +239% | +$12.5M |
|
133
Intuit
INTU
$188B
| $17.7M | 0.19% |
59,868
-10,345
| -15% | -$3.06M |
|
134
Sociedad Química y Minera de Chile
SQM
$13.2B
| $17.5M | 0.18% |
+670,400
| New | +$17.5M |
|
135
Synopsys
SNPS
$112B
| $17.5M | 0.18% |
89,560
+25,906
| +41% | +$5.05M |
|
136
NeoGenomics
NEO
$1.04B
| $17.4M | 0.18% |
562,098
+95,433
| +20% | +$2.96M |
|
137
XP
XP
$9.77B
| $17.4M | 0.18% |
413,000
+289,000
| +233% | +$12.1M |
|
138
Silicon Laboratories
SLAB
$4.46B
| $17.2M | 0.18% |
171,480
+59,947
| +54% | +$6.01M |
|
139
Morgan Stanley
MS
$235B
| $17.2M | 0.18% |
355,280
+43,937
| +14% | +$2.12M |
|
|
IBKC
140
DELISTED
IBERIABANK Corp
IBKC
| $17M | 0.18% |
374,285
+265,246
| +243% | +$12.1M |
|
141
Trimble
TRMB
$19B
| $16.9M | 0.18% |
391,903
-134,655
| -26% | -$5.82M |
|
|
MEET
142
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $16.7M | 0.18% |
+2,677,137
| New | +$16.7M |
|
143
Akebia Therapeutics
AKBA
$774M
| $16.7M | 0.18% |
+1,229,346
| New | +$16.7M |
|
144
Humana
HUM
$37.3B
| $16.6M | 0.18% |
42,805
+3,122
| +8% | +$1.21M |
|
145
Azenta
AZTA
$1.38B
| $16.6M | 0.18% |
374,787
+60,741
| +19% | +$2.69M |
|
146
Exact Sciences
EXAS
$10.1B
| $16.3M | 0.17% |
187,928
+71,571
| +62% | +$6.22M |
|
147
CBRE Group
CBRE
$48.4B
| $16.3M | 0.17% |
359,831
-31,912
| -8% | -$1.44M |
|
148
Newmont
NEM
$83.8B
| $16.3M | 0.17% |
263,291
-105,096
| -29% | -$6.49M |
|
149
Advanced Micro Devices
AMD
$246B
| $15.9M | 0.17% |
302,722
-77,836
| -20% | -$4.1M |
|
150
IBM
IBM
$229B
| $15.9M | 0.17% |
137,797
-10,493
| -7% | -$1.21M |
|